[
](https://coreem.net/podcast/episode-136-0/) )
This week we discuss some pearls and pitfalls when caring for HIV+ patients in the ED.
[https://media.blubrry.com/coreem/content.blubrry.com/coreem/Podcast_Episode_136_0_Final_Cut.m4a](https://media.blubrry.com/coreem/content.blubrry.com/coreem/Podcast_Episode_136_0_Final_Cut.m4a))
Download)
[One Comment](https://coreem.net/podcast/episode-136-0/#comments))
Tags: [AIDS](https://coreem.net/tag/aids/)), [HIV](https://coreem.net/tag/hiv/)), [Infectious Diseases](https://coreem.net/tag/infectious-diseases/)), [PCP](https://coreem.net/tag/pcp/)), [TB](https://coreem.net/tag/tb/)), [Tuberculosis](https://coreem.net/tag/tuberculosis/))
## Show Notes
HIV Associated Infections Based on CD4 Count (cooperhealth.org)
Total Lymphocyte Count = (% lymphocytes x WBC count)/100
TLC 1200 cells/mm3 correlated with CD4 count of < 200 cells/mm3 with a maximal sensitivity of 72.2%, and specificity of 100%
TLC1500 cells/mm3 correlated with CD4 count of 200 – 499 cells/mm3 with a maximal sensitivity of 96.7% and specificity of 100%
TLC 1900 cells/mm3 correlated with CD4 count of ≥ 500 cells/mm3 with a maximal sensitivity of 98.5% and specificity of 100%
Show Notes
REBEL EM: REBEL Cast Episode 1 – Total Lymphocyte Count as a Surrogate Marker for CD4 Count)
LITFL: HIV and AIDS)
References
Obirikorang C et al. Total Lymphocyte Count as a Surrogate Marker for CD4 Count in Resource-Limited. BMC Infectious Diseases Journal 2012; 12 (128): 1 – 5. PMID: 22676809